Viewing Study NCT03830866

Main Search All Studies All Organizations Report Bug

Ignite Creation Date: 2025-12-24 @ 4:25 PM

Ignite Modification Date: 2025-12-24 @ 4:25 PM

Study NCT ID: NCT03830866

Status: COMPLETED

Last Update Posted: 2024-07-26

First Post: 2018-12-04

Is Possible Gene Therapy: False

Has Adverse Events: True

Brief Title: Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

Sponsor: AstraZeneca

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module